Test Bank RN Pharmacology for Nursing
Edition 9.0 ATI Review Module Content
Mastery Series By Ali
Pharmacology - ANSWERStudy of biologic effects of chemicals.
Clinical Pharmacology - ANSWERApplication of pharmacology in patient care.
Pharmacotherapeutics - ANSWERUse of drugs to treat, prevent, diagnose diseases.
,Pharmacoeconomics - ANSWERCosts associated with drug therapy.
Pharmacodynamics - ANSWEREffects of drugs on the body.
Pharmacokinetics - ANSWERHow the body processes drugs.
Computed Tomography (CT) - ANSWERImaging technique using X-rays for diagnosis.
Chemotherapy - ANSWERDrug treatment for cancer management.
Measles-Mumps-Rubella Vaccine - ANSWERImmunization against three viral diseases.
Iodine Contrast - ANSWERSubstance used in imaging to enhance visibility.
Oncology Unit - ANSWERDepartment specializing in cancer treatment.
Public Health Department - ANSWERAgency focused on community health services.
Routine Immunization - ANSWERScheduled vaccinations for disease prevention.
Drug Administration - ANSWERProcess of giving medication to patients.
Nursing Role in Pharmacology - ANSWERNurses administer and monitor drug therapies.
Drug Therapy - ANSWERUse of medications to manage health conditions.
Patient Safety - ANSWERProtection of patients during drug administration.
Drug Diagnosis - ANSWERUsing drugs to assist in disease identification.
,Drug Treatment - ANSWERUsing medications to alleviate symptoms or cure.
Drug Prevention - ANSWERUsing medications to prevent disease occurrence.
Biologic Effects - ANSWERPhysiological responses to chemical substances.
Nurse's Responsibilities - ANSWEREnsure safe and effective medication administration.
Morphine - ANSWERA narcotic classified as Schedule II drug.
Schedule II - ANSWERDrugs with high abuse potential and accepted medical use.
Schedule I - ANSWERDrugs with high abuse potential, no medical use.
Schedule III - ANSWERDrugs with lesser abuse potential than Schedule II.
Schedule IV - ANSWERDrugs with low abuse potential and limited dependence.
Phase III studies - ANSWERInvolve vast clinical populations for drug evaluation.
Bioavailability - ANSWERPortion of drug reaching systemic circulation effectively.
Critical concentration - ANSWERAmount of drug needed for therapeutic effect.
Distribution - ANSWERMovement of drug to body tissues in pharmacokinetics.
Half-life - ANSWERTime for drug amount to decrease by half.
, Adverse effects - ANSWERNegative reactions experienced by patients during drug use.
FDA - ANSWERFood and Drug Administration, regulates drug approval.
Generic drugs - ANSWERMedications equivalent to brand-name drugs in dosage.
Brand name drugs - ANSWERMedications marketed under a trademarked name.
Narcotics - ANSWERDrugs with high potential for abuse and dependence.
Clinical population - ANSWERGroup of patients involved in drug studies.
Preclinical trials - ANSWERInitial drug testing phase using animal subjects.
Drug evaluation studies - ANSWERResearch to assess drug safety and effectiveness.
Medication safety - ANSWERAssessment of drug interactions and patient health.
Over-the-counter medications - ANSWERDrugs available without prescription.
Orphan drugs - ANSWERMedications for rare diseases with limited market.
Patient monitoring - ANSWERObserving patients for drug effects and safety.
Experimental drugs - ANSWERMedications under investigation for efficacy and safety.
Over-the-Counter Medications - ANSWERMedications patients may underestimate in importance.
Orphan Drugs - ANSWERMedications for rare diseases, often unknown to patients.
Edition 9.0 ATI Review Module Content
Mastery Series By Ali
Pharmacology - ANSWERStudy of biologic effects of chemicals.
Clinical Pharmacology - ANSWERApplication of pharmacology in patient care.
Pharmacotherapeutics - ANSWERUse of drugs to treat, prevent, diagnose diseases.
,Pharmacoeconomics - ANSWERCosts associated with drug therapy.
Pharmacodynamics - ANSWEREffects of drugs on the body.
Pharmacokinetics - ANSWERHow the body processes drugs.
Computed Tomography (CT) - ANSWERImaging technique using X-rays for diagnosis.
Chemotherapy - ANSWERDrug treatment for cancer management.
Measles-Mumps-Rubella Vaccine - ANSWERImmunization against three viral diseases.
Iodine Contrast - ANSWERSubstance used in imaging to enhance visibility.
Oncology Unit - ANSWERDepartment specializing in cancer treatment.
Public Health Department - ANSWERAgency focused on community health services.
Routine Immunization - ANSWERScheduled vaccinations for disease prevention.
Drug Administration - ANSWERProcess of giving medication to patients.
Nursing Role in Pharmacology - ANSWERNurses administer and monitor drug therapies.
Drug Therapy - ANSWERUse of medications to manage health conditions.
Patient Safety - ANSWERProtection of patients during drug administration.
Drug Diagnosis - ANSWERUsing drugs to assist in disease identification.
,Drug Treatment - ANSWERUsing medications to alleviate symptoms or cure.
Drug Prevention - ANSWERUsing medications to prevent disease occurrence.
Biologic Effects - ANSWERPhysiological responses to chemical substances.
Nurse's Responsibilities - ANSWEREnsure safe and effective medication administration.
Morphine - ANSWERA narcotic classified as Schedule II drug.
Schedule II - ANSWERDrugs with high abuse potential and accepted medical use.
Schedule I - ANSWERDrugs with high abuse potential, no medical use.
Schedule III - ANSWERDrugs with lesser abuse potential than Schedule II.
Schedule IV - ANSWERDrugs with low abuse potential and limited dependence.
Phase III studies - ANSWERInvolve vast clinical populations for drug evaluation.
Bioavailability - ANSWERPortion of drug reaching systemic circulation effectively.
Critical concentration - ANSWERAmount of drug needed for therapeutic effect.
Distribution - ANSWERMovement of drug to body tissues in pharmacokinetics.
Half-life - ANSWERTime for drug amount to decrease by half.
, Adverse effects - ANSWERNegative reactions experienced by patients during drug use.
FDA - ANSWERFood and Drug Administration, regulates drug approval.
Generic drugs - ANSWERMedications equivalent to brand-name drugs in dosage.
Brand name drugs - ANSWERMedications marketed under a trademarked name.
Narcotics - ANSWERDrugs with high potential for abuse and dependence.
Clinical population - ANSWERGroup of patients involved in drug studies.
Preclinical trials - ANSWERInitial drug testing phase using animal subjects.
Drug evaluation studies - ANSWERResearch to assess drug safety and effectiveness.
Medication safety - ANSWERAssessment of drug interactions and patient health.
Over-the-counter medications - ANSWERDrugs available without prescription.
Orphan drugs - ANSWERMedications for rare diseases with limited market.
Patient monitoring - ANSWERObserving patients for drug effects and safety.
Experimental drugs - ANSWERMedications under investigation for efficacy and safety.
Over-the-Counter Medications - ANSWERMedications patients may underestimate in importance.
Orphan Drugs - ANSWERMedications for rare diseases, often unknown to patients.
